1275086

Catalent Pharma Solutions, LLC — FEI 3007617094

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 5, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Philadelphia, PA (United States)